Trial Profile
Effect of paroxetine on glycaemic control and quality of life in mildly depressed type two diabetic subjects: a double-blind randomised placebo controlled six month trial
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 22 Aug 2023
Price :
$35
*
At a glance
- Drugs Paroxetine (Primary)
- Indications Depressive disorders
- Focus Therapeutic Use
- Sponsors GlaxoSmithKline; GSK
- 10 May 2007 New trial record.